| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |